Key Breast Journal Articles - Metastatic Chemo

First-line Treatment Options for Patients with HER-2 Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy
S Verma & M Clemons
Oncologist. July 2007; 12(7):785-797
Journal | Pubmed

Extending Survival with Chemotherapy in Metastatic Breast Cancer
J O'Shaughnessy
Oncologist. Oct 7 2005; 10 Suppl 3:20-9
Journal | Pubmed

A systematic review of taxane-containing regimens for metastatic breast cancer
D Ghersi, N Wilcken, & RJ Simes
Br J Cancer. Aug 8 2005; 93(3):293-301
Journal | Pubmed

Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)
GW Sledge, D Neuberg, P Bernardo, JN Ingle, S Martino, EK Rowinsky, & WC Wood
JCO. Feb 15 2003; 21(4):588-92
Journal | Pubmed

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results
J O’Shaughnessy, D Miles, S Vukelja, V Moiseyenko, JP Ayoub, G Cervantes, P Fumoleau, S Jones, WY Lui, L Mauriac, C Twelves, G Van Hazel, S Verma, & R Leonard
JCO. Jun 15 2002; 20(12):2812-23
Journal | Pubmed